In silico toxicology for the pharmaceutical sciences.
暂无分享,去创建一个
[1] R. Benigni. Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches. , 2005, Chemical reviews.
[2] R W Tennant,et al. Predicting chemical carcinogenesis in rodents. , 1993, Environmental health perspectives.
[3] Naomi L Kruhlak,et al. A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database. , 2007, Regulatory toxicology and pharmacology : RTP.
[4] Chihae Yang,et al. Toxicity Data Informatics: Supporting a New Paradigm for Toxicity Prediction , 2008, Toxicology mechanisms and methods.
[5] Gergana Dimitrova,et al. A Stepwise Approach for Defining the Applicability Domain of SAR and QSAR Models , 2005, J. Chem. Inf. Model..
[6] Luis G. Valerio,et al. In Silico Toxicological Screening of Natural Products , 2008, Toxicology mechanisms and methods.
[7] R Benigni,et al. Understanding Genetic Toxicity Through Data Mining: The Process of Building Knowledge by Integrating Multiple Genetic Toxicity Databases , 2008, Toxicology mechanisms and methods.
[8] S. Ekins. In silico approaches to predicting drug metabolism, toxicology and beyond. , 2003, Biochemical Society transactions.
[9] B. Testa,et al. Predicting drug metabolism: Concepts and challenges , 2004 .
[10] H. Rosenkranz,et al. Structural determinants of developmental toxicity in hamsters. , 1999, Teratology.
[11] Romualdo Benigni,et al. The Benigni / Bossa rulebase for mutagenicity and carcinogenicity - a module of Toxtree , 2008 .
[12] J Ashby,et al. Prediction of rodent carcinogenicity for 44 chemicals: results. , 1994, Mutagenesis.
[13] L. Bernstein,et al. Reproducibility of results in "near-replicate" carcinogenesis bioassays. , 1987, Journal of the National Cancer Institute.
[14] R Daniel Benz,et al. Toxicological and clinical computational analysis and the US FDA/CDER , 2007, Expert opinion on drug metabolism & toxicology.
[15] Anthony R Scialli,et al. The challenge of reproductive and developmental toxicology under REACH. , 2008, Regulatory toxicology and pharmacology : RTP.
[16] Registration, Evaluation and Authorisation of Chemicals , 2020 .
[17] M. A. Cabrera Pérez,et al. Quantitative structure-carcinogenicity relationship for detecting structural alerts in nitroso compounds: species, rat; sex, female; route of administration, gavage. , 2008, Chemical research in toxicology.
[18] H. Rosenkranz,et al. Structural Determinants of Developmental Toxicity1 , 1994 .
[19] J. Bailar,et al. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[20] Ursula Gundert-Remy,et al. The Use of (Q)SAR Methods in the Context of REACH , 2008, Toxicology mechanisms and methods.
[21] Naomi L Kruhlak,et al. Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action–Based Predictions of Chemical Carcinogenesis in Rodents , 2008, Toxicology mechanisms and methods.
[22] Naomi L Kruhlak,et al. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models. , 2007, Regulatory toxicology and pharmacology : RTP.
[23] C Helma,et al. Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. , 2001, Environmental health perspectives.
[24] J. Contrera,et al. Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices. , 2003, Regulatory toxicology and pharmacology : RTP.
[25] Peter C Jurs,et al. Predicting the genotoxicity of thiophene derivatives from molecular structure. , 2003, Chemical research in toxicology.
[26] Ilkka Ojanperä,et al. In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening. , 2009, Rapid communications in mass spectrometry : RCM.
[27] J C Madden,et al. Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier , 2007, SAR and QSAR in environmental research.
[28] Ronald D Snyder,et al. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity , 2009, Environmental and molecular mutagenesis.
[29] E Benfenati,et al. Computational predictive programs (expert systems) in toxicology. , 1997, Toxicology.
[30] D. Bristol,et al. The NIEHS Predictive-Toxicology Evaluation Project. , 1996, Environmental health perspectives.
[31] Aliuska Morales Helguera,et al. Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds: species: rat; sex: male; route of administration: water. , 2008, Toxicology and applied pharmacology.
[32] R. Snyder,et al. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules , 2004, Environmental and molecular mutagenesis.
[33] Naomi L Kruhlak,et al. Testing computational toxicology models with phytochemicals. , 2010, Molecular nutrition & food research.
[34] Kirk B Arvidson,et al. FDA toxicity databases and real-time data entry. , 2008, Toxicology and applied pharmacology.
[35] Naomi L Kruhlak,et al. A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals. , 2007, Regulatory toxicology and pharmacology : RTP.
[36] H. Rosenkranz,et al. Structural determinants associated with risk of human developmental toxicity. , 1997, American journal of obstetrics and gynecology.
[37] Tatiana Nikolskaya,et al. Early prediction of drug metabolism and toxicity: systems biology approach and modeling. , 2004, Drug discovery today.
[38] N. Kruhlak,et al. In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software. , 2005, Regulatory toxicology and pharmacology : RTP.
[39] E. Benfenati,et al. A combination of 3D-QSAR, docking, local-binding energy (LBE) and GRID study of the species differences in the carcinogenicity of benzene derivatives chemicals. , 2008, Journal of molecular graphics & modelling.
[40] A M Richard,et al. Structure-based methods for predicting mutagenicity and carcinogenicity: are we there yet? , 1998, Mutation research.
[41] L Zhang,et al. A regulatory viewpoint on transporter-based drug interactions. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[42] R. Tennant,et al. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. , 1988, Mutation research.
[43] Custer Ll,et al. The role of genetic toxicology in drug discovery and optimization. , 2008 .
[44] Carol A Marchant,et al. In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic , 2008, Toxicology mechanisms and methods.
[45] H. Rosenkranz,et al. Structural determinants of developmental toxicity. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.
[46] A.M. Richard,et al. AI and SAR approaches for predicting chemical carcinogenicity: Survey and status report , 2002, SAR and QSAR in environmental research.
[47] Y T Woo,et al. Development of structure-activity relationship rules for predicting carcinogenic potential of chemicals. , 1995, Toxicology letters.
[48] C. Dobson. Chemical space and biology , 2004, Nature.
[49] R Daniel Benz,et al. Landscape of current toxicity databases and database standards. , 2006, Current opinion in drug discovery & development.
[50] Michael S Victoroff,et al. Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.
[51] Sean Ekins,et al. Methods for predicting human drug metabolism. , 2007, Advances in clinical chemistry.
[52] I C Munro,et al. Thresholds of toxicological concern based on structure-activity relationships. , 1996, Drug metabolism reviews.
[53] C. D. De Rosa,et al. Prediction of the health effects of polychlorinated biphenyls (PCBs) and their metabolites using quantitative structure-activity relationship (QSAR). , 2008, Toxicology letters.
[54] S. Ekins,et al. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[55] M. Cronin,et al. Pitfalls in QSAR , 2003 .
[56] E. Hulzebos,et al. (Q)SARS: gatekeepers against risk on chemicals? , 2003, SAR and QSAR in environmental research.
[57] B Testa,et al. In silico pharmacology for drug discovery: applications to targets and beyond , 2007, British journal of pharmacology.
[58] Romualdo Benigni,et al. Predictivity and Reliability of QSAR Models: The Case of Mutagens and Carcinogens , 2008, Toxicology mechanisms and methods.
[59] A. Hopkins,et al. Navigating chemical space for biology and medicine , 2004, Nature.
[60] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[61] Naomi L. Kruhlak,et al. In Silico Screening of Chemicals for Genetic Toxicity Using MDL-QSAR, Nonparametric Discriminant Analysis, E-State, Connectivity, and Molecular Property Descriptors , 2008, Toxicology mechanisms and methods.
[62] Naomi L Kruhlak,et al. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products. , 2007, Advanced drug delivery reviews.
[63] Robert J Kavlock,et al. Computational toxicology--a state of the science mini review. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[64] Innovation OR Stagnation. Challenge and Opportunity on the Critical Path to New Medical Products , 2004 .
[65] T. Nikolskaya,et al. A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT , 2006, Drug Metabolism and Disposition.
[66] David B Duignan,et al. High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models. , 2008, Current drug metabolism.
[67] M J Prival,et al. Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals , 2001, Environmental and molecular mutagenesis.
[68] Hongshi Yu,et al. ADME-Tox in drug discovery: integration of experimental and computational technologies. , 2003, Drug discovery today.
[69] John D. Walker,et al. Quantitative structure–activity relationships (QSARs) in toxicology: a historical perspective , 2003 .
[70] Lemont B. Kier,et al. Modeling Drug Albumin Binding Affinity with E-State Topological Structure Representation , 2003, J. Chem. Inf. Comput. Sci..
[71] S. Ekins,et al. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling , 2007, British journal of pharmacology.
[72] Sean Ekins,et al. The importance of discerning shape in molecular pharmacology. , 2009, Trends in pharmacological sciences.
[73] P N Judson,et al. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.
[74] G. Klebe,et al. Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model. , 2004, Journal of medicinal chemistry.
[75] Gilles Klopman,et al. META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals , 1994, J. Chem. Inf. Comput. Sci..
[76] Sean Ekins,et al. Shape signatures: new descriptors for predicting cardiotoxicity in silico. , 2008, Chemical research in toxicology.
[77] R A Ford,et al. Estimation of toxic hazard--a decision tree approach. , 1978, Food and cosmetics toxicology.
[78] Mark T. D. Cronin,et al. The present status of QSAR in toxicology , 2003 .
[79] Weida Tong,et al. Mold2, Molecular Descriptors from 2D Structures for Chemoinformatics and Toxicoinformatics , 2008, J. Chem. Inf. Model..
[80] Joseph F Contrera,et al. QSAR modeling of carcinogenic risk using discriminant analysis and topological molecular descriptors. , 2005, Current drug discovery technologies.
[81] Durham Sk,et al. Computational methods to predict drug safety liabilities. , 2001 .
[82] Sean Ekins,et al. Computational prediction of human drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.
[83] N. Kruhlak,et al. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. , 2006, Regulatory toxicology and pharmacology : RTP.
[84] K. Sweder,et al. The role of genetic toxicology in drug discovery and optimization. , 2008, Current drug metabolism.
[85] Romualdo Benigni,et al. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology. , 2008, Mutation research.
[86] A. Jacobs. Prediction of 2-year carcinogenicity study results for pharmaceutical products: how are we doing? , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[87] A. Bailey,et al. The use of structure-activity relationship analysis in the food contact notification program. , 2005, Regulatory toxicology and pharmacology : RTP.
[88] Thomas Bäck,et al. Substructure Mining Using Elaborate Chemical Representation , 2006, J. Chem. Inf. Model..
[89] Naomi L Kruhlak,et al. Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models , 2008, Toxicology mechanisms and methods.
[90] Vijay K. Gombar,et al. A QSAR Model of Teratogenesis , 1991 .
[91] Péter Csermely,et al. The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.
[92] R Benigni. The first US National Toxicology Program exercise on the prediction of rodent carcinogenicity: definitive results. , 1997, Mutation research.
[93] Xin Chen,et al. Virtual screening to successfully identify novel janus kinase 3 inhibitors: a sequential focused screening approach. , 2008, Journal of medicinal chemistry.
[94] R. Kroes. Structure-Based Thresholds of Toxicological Concern (TTC): Guidance for Application to Substances Present at Low Levels in the Diet , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[95] R. Burghardt,et al. Using Quantitative Structure–Activity Relationships (QSAR) to Predict Toxic Endpoints for Polycyclic Aromatic Hydrocarbons (PAH) , 2008, Journal of toxicology and environmental health. Part A.
[96] M A Cheeseman,et al. Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens. , 2008, Regulatory toxicology and pharmacology : RTP.
[98] Joelle M. R. Gola,et al. Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery , 2006, Expert opinion on drug metabolism & toxicology.
[99] K. Enslein,et al. Use of SAR in computer-assited prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program , 1994 .
[100] Romualdo Benigni,et al. The second National Toxicology Program comparative exercise on the prediction of rodent carcinogenicity: definitive results. , 2004, Mutation research.
[101] Vladimir Potemkin,et al. Principles for 3D/4D QSAR classification of drugs. , 2008, Drug discovery today.
[102] Sarah N. Hilmer,et al. ADME-tox issues for the elderly , 2008 .
[103] J W Green,et al. A review of the genotoxicity of marketed pharmaceuticals. , 2001, Mutation research.
[104] Wolfgang Muster,et al. Computational toxicology in drug development. , 2008, Drug discovery today.
[105] R. Tennant,et al. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.
[106] K Enslein,et al. International Commission for Protection Against Environmental Mutagens and Carcinogens. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program. , 1994, Mutation research.
[107] J Ashby,et al. International Commission for Protection Against Environmental Mutagens and Carcinogens. Two million rodent carcinogens? The role of SAR and QSAR in their detection. , 1994, Mutation research.
[108] Florian Nigsch,et al. Computational toxicology: an overview of the sources of data and of modelling methods , 2009, Expert opinion on drug metabolism & toxicology.
[109] Shane Weaver,et al. The importance of the domain of applicability in QSAR modeling. , 2008, Journal of molecular graphics & modelling.
[110] Edwin J Matthews,et al. In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects , 2007, Expert opinion on drug metabolism & toxicology.
[111] C. Hansch,et al. A NEW SUBSTITUENT CONSTANT, PI, DERIVED FROM PARTITION COEFFICIENTS , 1964 .
[112] Robert D Clark,et al. Modelling in vitro hepatotoxicity using molecular interaction fields and SIMCA. , 2004, Journal of molecular graphics & modelling.
[113] Tingjun Hou,et al. Recent development and application of virtual screening in drug discovery: an overview. , 2004, Current pharmaceutical design.
[114] Sean Ekins,et al. Combined Computational Metabolite Prediction and Automated Structure-Based Analysis of Mass Spectrometric Data , 2008, Toxicology mechanisms and methods.
[115] E Gottmann,et al. Data quality in predictive toxicology: identification of chemical structures and calculation of chemical properties. , 2000, Environmental health perspectives.
[116] R Purdy,et al. A mechanism-mediated model for carcinogenicity: model content and prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 25 organic chemicals. , 1996, Environmental health perspectives.
[117] G M Pearl,et al. Integration of computational analysis as a sentinel tool in toxicological assessments. , 2001, Current topics in medicinal chemistry.
[118] A. Vedani,et al. Mixed-model QSAR at the human mineralocorticoid receptor: predicting binding mode and affinity of anabolic steroids. , 2009, Toxicology letters.
[119] Sean Ekins,et al. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. , 2005, Trends in pharmacological sciences.
[120] J. Ashby. Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. , 1985, Environmental mutagenesis.
[121] Joseph F Contrera,et al. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[122] E. Benfenati,et al. QSAR modelling of carcinogenicity by balance of correlations , 2009, Molecular Diversity.
[123] V. Armstrong,et al. The Assessment and Management of Industrial Chemicals in Canada , 2007 .
[124] Maykel Pérez González,et al. QSAR modeling of the rodent carcinogenicity of nitrocompounds. , 2008, Bioorganic & medicinal chemistry.
[125] Ann M Richard,et al. A novel approach: chemical relational databases, and the role of the ISSCAN database on assessing chemical carcinogenicity. , 2008, Annali dell'Istituto superiore di sanita.
[126] Lg Valerio. Tools for evidence-based toxicology: computational-based strategies as a viable modality for decision support in chemical safety evaluation and risk assessment , 2008, Human & experimental toxicology.
[127] Luis G Valerio,et al. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling. , 2007, Toxicology and applied pharmacology.
[128] J. Kazius,et al. Derivation and validation of toxicophores for mutagenicity prediction. , 2005, Journal of medicinal chemistry.
[129] Gisbert Schneider,et al. Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.
[130] Theo Vermeire,et al. Risk assessment of chemicals , 2021, Bioanalytical Tools in Water Quality Assessment.
[131] R. Tennant,et al. Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the National Toxicology Program. , 1990, Mutagenesis.
[132] Petra S Kern,et al. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. , 2007, Chemical research in toxicology.